View More Recent Stories
-
West Pharma (WST) Declares $0.21 Quarterly Dividend; 0.2% Yield
-
KeyBanc Highlights WST, GXIG, and STVN as GLP-1 Estimates Raise
-
Citi Starts West Pharmaceutical (WST) at Buy
-
KeyBanc Weighs in on GLP-1 Injection Leaders Following Latest NVO Results
-
Wolfe Research Starts West Pharmaceutical (WST) at Peerperform
-
West Pharma (WST) Names Janet Haugen to Board
-
Jefferies Reiterates Buy Rating on West Pharmaceutical (WST)
-
West Pharma (WST) 1450 contracts of January 300 puts trade
-
West Pharma (WST) Tops Q3 EPS by 35c, provides guidance
-
West Pharma (WST) to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference
-
West Pharma (WST) August 250 puts active as share price down 9%
-
West Pharma (WST) Misses Q2 EPS by 22c; cuts guidance

